Exploring the benefits, harms, and costs of genomic newborn screening for rare diseases
View/ Open
Accepted version
Embargoed until: 2024-12-18
Embargoed until: 2024-12-18
Publisher
DOI
doi.org/10.1038/s41591-024-03055-x
Journal
Nature Medicine
ISSN
1546-170X